ERBB2 and neoplasm: rMVA-CD40L-mediated tumor growth control was achieved not only when using exogenous model antigens such as OVA or human antigens as HER2 encoded by the vaccine, but also when expressing either the endogenous retroviral elements p15E or AH-1A5 in WT tumor models lacking exogenous tumor antigens.